Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02301793 · ClinicalTrials.gov registry record · NA
Educating Nurses About Venous Thromboembolism (VTE) Prevention
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 933
- Enrollment target
NCT02301793: Completed NA study, sponsored by Johns Hopkins University.
NCT02301793 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 933 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02301793, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 933 participants
- Enrollment target
Study Summary
As part of mandatory on-going nursing education, the investigators have incorporated identical information into two distinct web-based learning formats - the traditional linear PowerPoint format (with voice-over) and a new interactive format developed with central nursing education. The investigators will cluster randomize nurses by floor to receive either the traditional education or the new interactive education, and evaluate the impact on administration of VTE prophylaxis doses administered by nurses before and after education. All nurses on a floor will receive the same educational format. If one method of education results in statistically significant improvement in VTE prophylaxis administration, the investigators will cross over to deliver the superior education format to all nurses who originally were given the less effective method.
Primary Outcome
This is the percentage of VTE prophylaxis doses that were not administered for any reason as documented in the electronic health record by a nurse
Interventions
- BEHAVIORAL Nurse education in contemporary format
- BEHAVIORAL Nurse education in traditional format
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 933 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2015-03-31 |
| Phase | NA |
What the finished NCT02301793 record still lists
NCT02301793 is an interventional study that assigns participants to a tested intervention. The registered 933 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 2 interventions - of which Nurse education in contemporary format is the first listed.
NCT02301793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02301793 about?
NCT02301793 is a clinical study titled "Educating Nurses About Venous Thromboembolism (VTE) Prevention". As part of mandatory on-going nursing education, the investigators have incorporated identical information into two distinct web-based learning formats - the traditional linear PowerPoint format (with voice-over) and a new interactive format developed with central nursing education. The investigato...
What is the current status of trial NCT02301793?
This trial is currently completed. It is a NA study. The enrollment target is 933 participants. The study started on 2014-04-01. Estimated completion is 2015-03-31.
What interventions are being tested in trial NCT02301793?
The interventions under investigation include: Nurse education in contemporary format (BEHAVIORAL), Nurse education in traditional format (BEHAVIORAL).
Who is sponsoring clinical trial NCT02301793?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02301793's enrollment target sits among peer trials
933 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04626635 · 933 participants · Phase 1
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
- NCT05519007 · 936 participants · NA
Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone
- NCT05216432 · 930 participants · Phase 1
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
- NCT06932029 · 930 participants · NA
SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI